<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T22:55:08Z</responseDate>
  <request identifier="oai:figshare.com:article/33719029" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33719029</identifier>
        <datestamp>2026-09-14T05:40:33Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_Tissue-nonspecific alkaline phosphatase deficiency is associated with altered immune cell profiles in hypophosphatasia.docx</dc:title>
          <dc:creator>Luis Martínez-Heredia (17722704)</dc:creator>
          <dc:creator>Manuel Muñoz-Torres (695278)</dc:creator>
          <dc:creator>Trinidad González-Cejudo (17722710)</dc:creator>
          <dc:creator>María Dolores López-Robles (24868414)</dc:creator>
          <dc:creator>Mónica Cabeo (24868417)</dc:creator>
          <dc:creator>Ángel Carazo-Gallego (24868420)</dc:creator>
          <dc:creator>Enrique García-Recio (24868423)</dc:creator>
          <dc:creator>Sheila González-Salvatierra (17722716)</dc:creator>
          <dc:creator>Victoria Contreras-Bolívar (17722713)</dc:creator>
          <dc:creator>María Carmen Andreo-López (24868426)</dc:creator>
          <dc:creator>Iván Iglesias-Baena (261499)</dc:creator>
          <dc:creator>Francisco Andújar-Vera (5435450)</dc:creator>
          <dc:creator>Cristina García-Fontana (133781)</dc:creator>
          <dc:creator>Beatriz García-Fontana (2221810)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>calprotectin</dc:subject>
          <dc:subject>flow cytometry</dc:subject>
          <dc:subject>hypophosphatasia</dc:subject>
          <dc:subject>immune-mediated inflammatory diseases</dc:subject>
          <dc:subject>TNSALP</dc:subject>
          <dc:description>Background&lt;p&gt;Hypophosphatasia (HPP) is a rare metabolic disorder caused by mutations in the ALPL gene leading to tissue-nonspecific alkaline phosphatase (TNSALP) deficiency. Although traditionally considered a skeletal disease, emerging evidence suggests an immunomodulatory role for TNSALP in systemic inflammation and immune-mediated inflammatory diseases (IMIDs). This study investigated clinical, biochemical, and immunological features associated with inflammation in HPP.&lt;/p&gt;Methods&lt;p&gt;Forty-seven genetically confirmed HPP patients and 30 healthy controls with a comparable age and sex distribution were evaluated. Analyses included serum alkaline phosphatase (ALP), bone-specific ALP (BALP), C-reactive protein (CRP), fecal calprotectin (FCP), and flow cytometry in a subset of 29 HPP patients and 26 controls to assess leukocyte subpopulations and TNSALP expression, with confirmation by confocal microscopy.&lt;/p&gt;Results&lt;p&gt;HPP patients exhibited reduced TNSALP expression in T cells, B cells, neutrophils, and monocytes, together with lower CD3 and CD8 fluorescence intensity and an increased CD16+/CD14+ monocyte ratio. IMIDs were frequent in this referral cohort and were associated with lower ALP and higher FCP. Within the flow-cytometry subset, lower proportions of CD8+ cells within the CD3−/CD19− NK-enriched population and of TNSALP+ B cells were associated with IMID status.&lt;/p&gt;Discussion&lt;p&gt;These cross-sectional findings identify an association between TNSALP deficiency and a coordinated immune-inflammatory phenotype in HPP. They support the biological plausibility of an immunomodulatory role for TNSALP but do not establish that TNSALP deficiency causes inflammation or the development of IMIDs.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-14T05:40:33Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1906557.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_Tissue-nonspecific_alkaline_phosphatase_deficiency_is_associated_with_altered_immune_cell_profiles_in_hypophosphatasia_docx/33719029</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
